Trials / Conditions / Hookworm Infections

Hookworm Infections

13 registered clinical trials studyying Hookworm Infections — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Moxidectin Versus Ivermectin as Mass Drug Administration for the Control of Onchocerciasis and Other Neglected NCT07145736	Kirby Institute	Phase 4
Completed	Efficacy, Safety and Acceptability of Ivermectin ODT in PSAC NCT06184399	Jennifer Keiser	Phase 2
Completed	Efficacy and Safety of Moxidectin-Albendazole Co-administration in SAC NCT06188715	Jennifer Keiser	Phase 3
Completed	Efficacy and Safety of Emodepside in Adolescents and Adults Infected With Hookworm NCT05538767	Jennifer Keiser	Phase 2
Completed	Efficacy and Safety of Emodepside in Adults Infected With Trichuris Trichiura and Hookworm NCT05017194	Jennifer Keiser	Phase 2
Completed	Efficacy and Safety of MOX/ALB Co-administration NCT04726969	Jennifer Keiser	Phase 3
Completed	Efficacy and Safety of MOX/ALB vs. IVM/ALB Co-administration NCT04700423	Jennifer Keiser	Phase 2 / Phase 3
Completed	Efficacy and Safety of a New Chewable Versus the Swallowable Tablet of Mebendazole Against Hookworm NCT03995680	Swiss Tropical & Public Health Institute	Phase 2
Unknown	Soil-transmitted Helminth Reinfection Rates After Single and Repeated School Hygiene Education NCT04227834	Universitas Sumatera Utara	N/A
Completed	Albendazole Dose Finding and Pharmacokinetics in Children and Adults NCT03527745	Jennifer Keiser	Phase 2
Completed	Efficacy of Na-GST-1/Alhydrogel Hookworm Vaccine Assessed by Controlled Challenge Infection NCT03172975	Baylor College of Medicine	Phase 2
Withdrawn	Mebendazole Study Against Hookworm Infections in Children and Adolescents in Ghana NCT03261596	PATH	Phase 4
Completed	Iron Absorption and Utilization in Adolescents Infected With Malaria Parasites, Hookworms or Schistosoma NCT01163877	Swiss Federal Institute of Technology	N/A